Narasimha Swamy Thirukovela

Synthesis and biological evaluation of novel [1,2,3]triazolo-pyrrolo[1,2-a]pyrido[4,3-d]pyrimidines as EGFR targeting anticancer agents

Sandhya Rani Bandi, Natte Kavitha, Satheesh Kumar Nukala et al. · Journal of Molecular Structure · 2022 · 42 citations

Medicinal Chemistry, Medicine, Pharmacological Agent +9

Cu(I)‐Catalyzed One‐Pot Synthesis of [1,2,3]Triazolo[5,1‐ <i>a</i> ] isoquinolin‐6(5H)‐one Derivatives as EGFR‐Targeting Anticancer Agents

Rajkumar Samala, Satheesh Kumar Nukala, Narasimha Swamy Thirukovela et al. · ChemistrySelect · 2022 · 35 citations

Synthesis and Biological Evaluation of Benzo[d] thiazolyl‐Sulfonyl‐Benzo[4,5]isothiazolo [2,3‐c][1,2,3] triazole Derivatives as EGFR Targeting Anticancer Agents

E. Ramya Sucharitha, Satheesh Kumar Nukala, Narasimha Swamy Thirukovela et al. · ChemistrySelect · 2023 · 35 citations · Full text

Organic Chemistry, Pharmacotherapy, One‐step Procedure +17

Synthesis of new morpholine-benzimidazole-pyrazole hybrids as tubulin polymerization inhibiting anticancer agents

Ravikumar Reddy Sagam, Satheesh Kumar Nukala, Rajkumar Nagavath et al. · Journal of Molecular Structure · 2022 · 31 citations

Medicinal Chemistry, Polymer-drug Conjugate, New Morpholine-benzimidazole-pyrazole Hybrids +9

In‐vitro Anticancer and Molecular Docking Studies of 4‐Azaindole‐1,2,4‐Oxadiazole Hybrids

Ravikumar Reddy Sagam, Satheesh Kumar Nukala, Rajkumar Nagavath et al. · ChemistrySelect · 2021 · 29 citations

Molecular Docking Studies, Medicinal Chemistry, Diversity Oriented Synthesis +11